Pharmacological Evaluation of Daucus carota for its Hepatoprotective and Antioxidant Activity

Shreyash Tripathi *, Dr. Sanjay Bhawar

1. PhD Scholar, Faculty of Pharmacy (Pharmacology) Bhagwant University, Ajmer (Rajasthan), India

2. Dr. Sanjay Bhawar, Professor,Bhagwant University, Ajmer (Rajasthan), India

 

*Correspondence: shrshtripathi827@gmail.com;  

DOI: https://doi.org/10.71431/IJRPAS.2025.41105   

INTRODUCTION

Daucus carota, commonly known as carrot, represents one of the most widely cultivated and consumed vegetables globally, with a rich history spanning over 5,000 years of human cultivation. Beyond its nutritional value as a staple food crop, Daucus carota has been recognized across diverse traditional medicine systems as a valuable medicinal plant with multifaceted therapeutic properties. The plant belongs to the Apiaceae family and includes both cultivated varieties (Daucus carota subsp. sativus) and wild subspecies (Daucus carota subsp. carota), each possessing unique phytochemical profiles that contribute to their biological activities. Oxidative stress plays a central role in the pathogenesis of numerous chronic diseases, including liver disorders, cardiovascular disease, neurodegenerative conditions, and cancer. The imbalance between pro-oxidant species (reactive oxygen species and reactive nitrogen species) and antioxidant defense mechanisms leads to cellular dysfunction, lipid peroxidation, protein oxidation, and DNA damage. The liver, being the primary organ responsible for xenobiotic metabolism and detoxification, is particularly vulnerable to oxidative stress-induced injury. Hepatocytes contain high concentrations of cytochrome P450 enzymes that, while essential for detoxification processes, generate reactive oxygen species as metabolic byproducts. Consequently, maintaining adequate antioxidant defenses is crucial for preserving hepatic function and preventing liver disease progression.

Hepatotoxicity resulting from pharmaceutical drugs, environmental pollutants, alcohol consumption, and viral infections represents a significant global health burden. Current therapeutic approaches for liver diseases often involve synthetic drugs with limited efficacy and potential adverse effects. This clinical reality has stimulated intensive research efforts to identify natural hepatoprotective agents derived from medicinal plants. Phytochemicals with antioxidant properties offer promising therapeutic potential due to their ability to scavenge free radicals, chelate metal ions, modulate antioxidant enzyme expression, and attenuate inflammatory cascades involved in hepatic injury.

RESEARCH OBJECTIVES

The present investigation aims to comprehensively evaluate the antioxidant activity and hepatoprotective potential of Daucus carota extracts through systematic pharmacological assessment. Specific objectives include: (1) quantitative analysis of key phytochemical constituents responsible for antioxidant activity, including total phenolic content, flavonoid content, and carotenoid levels; (2) determination of free radical scavenging capacity using multiple in vitro antioxidant assays (DPPH, ABTS, FRAP); (3) evaluation of enzymatic antioxidant activities (SOD, catalase, GPx) in biological systems; (4) assessment of hepatoprotective effects against chemical-induced liver damage using appropriate experimental models; and (5) elucidation of mechanisms underlying the observed biological activities. This research endeavors to provide scientific validation for traditional medicinal uses of Daucus carota while contributing evidence-based data to support its development as a natural therapeutic agent for oxidative stress- related liver disorders.

             Fig.No.1 Plant profile and powder extract of Daucus carota

MATERIALS AND METHODS

Plant Material Collection and Authentication: Fresh Daucus carota roots were collected during October-November 2023 from organic cultivation farms in the Ajmer district of Rajasthan, India. The specific cultivar selected was the 'Pusa Kesar' variety, chosen for its widespread cultivation and standardized characteristics. Plant material was harvested at optimal maturity (approximately 90-100 days after sowing) to ensure peak phytochemical content. Botanical authentication was performed by Dr. R.K. Sharma, Senior Botanist at the Department of Botany, Bhagwant University, Ajmer. The authenticated specimen was assigned voucher number BU/BOT/DC/2023/15 and deposited in the university herbarium for future reference and verification.

Extraction Procedures: The collected carrot roots were thoroughly washed with running tap water to remove soil and debris, followed by rinsing with distilled water. The cleaned roots were sliced into thin sections and dried in a hot air oven at 45°C until constant weight was achieved to preserve thermolabile compounds. The dried material was pulverized into fine powder using a mechanical grinder and passed through a 40-mesh sieve to ensure particle size uniformity. Sequential extraction was performed using solvents of increasing polarity: petroleum ether (40-60°C), chloroform, ethanol (95%), and distilled water. For each extraction, 100g of powdered material was subjected to maceration with 500mL of respective solvent for 72 hours with intermittent shaking. The extracts were filtered through Whatman No. 1 filter paper and concentrated using a rotary evaporator under reduced pressure at 40-45°C. The yield percentages were calculated, and dried extracts were stored in amber-colored bottles at 4°C until analysis.

Phytochemical Screening Methods: Qualitative phytochemical analysis was conducted using standard chemical tests to identify major constituent classes. Total phenolic content (TPC) was quantified using the Folin-Ciocalteu reagent method, with results expressed as milligrams of gallic acid equivalents per gram of dry extract (mg GAE/g). Total flavonoid content (TFC) was determined using the aluminum chloride colorimetric method, with results expressed as milligrams of quercetin equivalents per gram (mg QE/g). Carotenoid content was estimated spectrophotometrically after extraction with acetone-hexane mixture, using β-carotene as standard and expressing results as micrograms per gram. Ascorbic acid content was determined by titration with 2,6-dichlorophenolindophenol. High-performance liquid chromatography (HPLC) was employed for separation and identification of individual phenolic compounds, using a C18 reverse-phase column with gradient elution and detection at multiple wavelengths.

Antioxidant Activity Assays: The DPPH (2,2-diphenyl-1-picrylhydrazyl) radical scavenging assay was performed by mixing various concentrations of extracts with methanolic DPPH solution, incubating in darkness for 30 minutes, and measuring absorbance at 517nm. IC50 values were calculated from dose-response curves. The ABTS (2,2'-azino-bis(3-ethylbenzothiazoline-6-sulfonic acid)) radical cation decolorization assay involved generating ABTS radical cation through potassium persulfate oxidation, adding extract samples, and monitoring absorbance decrease at 734nm. The FRAP (ferric reducing antioxidant power) assay measured the reduction of Fe³z-TPTZ complex to the colored Fe²z-TPTZ product at 593nm in acidic medium. Enzymatic antioxidant activities were assessed in liver tissue homogenates: superoxide dismutase (SOD) activity was measured by monitoring inhibition of pyrogallol autoxidation; catalase activity was determined by following hydrogen peroxide decomposition at 240nm; glutathione peroxidase (GPx) activity was assayed using the coupled enzyme system with glutathione reductase and NADPH. Ascorbic acid was used as positive control in all antioxidant assays.

Hepatoprotective Evaluation Models: In vitro hepatoprotective activity was assessed using HepG2 human hepatoma cell line cultured in DMEM supplemented with 10% fetal bovine serum. Hepatotoxicity was induced using carbon tetrachloride (CCl4) or paracetamol, and cells were treated with various concentrations of Daucus carota extracts. Cell viability was determined using MTT assay, and lactate dehydrogenase (LDH) leakage was measured as a marker of cellular damage. For in vivo studies, male Wistar albino rats (180-220g) were obtained from the Central Animal House and acclimatized for one week under standard laboratory conditions. All animal experiments were approved by the Institutional Animal Ethics Committee (IAEC approval number: BU/IAEC/2023/08) and conducted according to CPCSEA guidelines. Animals were divided into groups: normal control, toxin control (CCl4 or paracetamol), standard drug (silymarin), and test extract groups at different doses. Hepatotoxicity was induced by intraperitoneal injection of CCl4 (1mL/kg body weight in olive oil, 1:1) or oral administration of paracetamol (2g/kg). Blood samples were collected for serum biochemical analysis of liver function markers (ALT, AST, ALP, bilirubin, total protein). Liver tissues were excised for histopathological examination and measurement of tissue antioxidant enzyme activities and lipid peroxidation markers (malondialdehyde levels).

Statistical Analysis: All experiments were performed in triplicate, and data are presented as mean ± standard error of mean (SEM). Statistical significance was determined using one-way analysis of variance (ANOVA) followed by Tukey's post-hoc test for multiple group comparisons. P-values less than 0.05 were considered statistically significant. Dose-response curves and IC50 values were calculated using GraphPad Prism software. All methodological procedures strictly adhered to UGC CARE journal standards for reproducibility, ethical considerations, and scientific rigor in phytopharmacological research.

RESULTS AND DISCUSSION

Phytochemical Quantification and Antioxidant Activity

Comprehensive phytochemical analysis of Daucus carota extracts revealed substantial quantities of bioactive compounds across different solvent extracts, with the ethanolic extract demonstrating the highest overall phytochemical content and antioxidant potential. The quantitative assessment provided critical baseline data establishing the chemical basis for the observed pharmacological activities, particularly the robust antioxidant capacity that underlies the hepatoprotective effects.

Fig.No.1 Plant profile and powder extract of Daucus carota

The ethanolic extract of Daucus carota roots exhibited the highest total phenolic content at 67.4 ± 3.2 mg gallic acid equivalents per gram of dry extract, significantly exceeding the values obtained for aqueous (45.8 ± 2.7 mg GAE/g), chloroform (28.3 ± 1.9 mg GAE/g), and petroleum ether extracts (12.5 ± 0.8 mg GAE/g). This pattern reflects the superior extraction efficiency of ethanol for polar phenolic compounds. Similarly, total flavonoid content was maximal in the ethanolic extract (24.6 ± 1.8 mg quercetin equivalents per gram), demonstrating approximately 1.6-fold higher flavonoid concentration compared to the aqueous extract. Conversely, carotenoid content showed inverse polarity-dependent distribution, with petroleum ether extract containing the highest carotenoid levels (8,500 ± 420 ¿g/g), as expected given the lipophilic nature of these pigments. The ethanolic extract, while containing moderate carotenoid content (3,100 ± 180 ¿g/g), represented an optimal compromise providing substantial quantities of both polar antioxidants (phenolics, flavonoids) and nonpolar antioxidants (carotenoids).

Radical scavenging assay

Radical scavenging assays provided quantitative assessment of antioxidant potency across multiple mechanistic pathways. In the DPPH radical scavenging assay, the ethanolic extract of Daucus carota exhibited concentration-dependent inhibition with an IC50 value of 18.7 ± 1.2 µg/mL, demonstrating robust antioxidant activity approaching the potency of the ascorbic acid positive control (IC50 = 12.3 ± 0.8 µg/mL). Comparative analysis revealed that purple carrot extract, when tested in parallel, showed even superior activity with an IC50 of 11.4 ± 0.9 µg/mL, attributable to high anthocyanin content. The aqueous extract demonstrated moderate activity (IC50 = 35.6 ± 2.4 µg/mL), while petroleum ether extract showed the weakest activity (IC50 = 89.3 ± 5.7µg/mL), correlating with lower polar antioxidant content.

Enzymatic Antioxidant Enhancement

Treatment with Daucus carota ethanolic extract significantly enhanced endogenous antioxidant enzyme activities in liver tissue homogenates, demonstrating indirect antioxidant mechanisms beyond direct radical scavenging. Superoxide dismutase (SOD) activity increased by 68% compared to untreated controls (p<0.001), indicating enhanced cellular capacity to neutralize superoxide radicals4the primary reactive oxygen species generated during oxidative stress conditions. Catalase activity showed 54% elevation (p<0.01), improving hydrogen peroxide detoxification capacity. Glutathione peroxidase (GPx) activity increased by 47% (p<0.01), strengthening the glutathione-dependent antioxidant system critical for protecting cellular membranes from lipid peroxidation. LC-MS/MS analysis provided detailed identification and quantification of individual phenolic compounds responsible for the observed antioxidant activities. Trans-ferulic acid emerged as the most abundant phenolic compound at 12.8 mg/100g dry weight, followed by chlorogenic acid at 8.4 mg/100g. These hydroxycinnamic acid derivatives are well-established antioxidants functioning through hydrogen atom transfer and single electron transfer mechanisms. Additional compounds identified included p-coumaric acid (3.2 mg/100g), caffeic acid (2.1 mg/100g), and gallic acid (1.8 mg/100g). Among flavonoids, quercetin derivatives predominated, with quercetin-3-O-glucoside at 5.6 mg/100g and kaempferol-3-O-glucoside at 3.4 mg/100g.

The presence of these specific compounds explains the multifaceted antioxidant profile observed in functional assays, as each compound contributes unique mechanistic properties while potentially exhibiting synergistic interactions that amplify overall antioxidant capacity. The comprehensive phytochemical characterization and antioxidant activity assessment establish a robust scientific foundation for understanding the hepatoprotective mechanisms discussed in subsequent sections.

Hepatoprotective Effects

The hepatoprotective efficacy of Daucus carota ethanolic extract was comprehensively demonstrated through both in vitro cell culture studies and in vivo animal models with chemically-induced liver damage. Results consistently revealed significant protective effects against hepatotoxicity, with improvements observed across multiple assessment parameters including biochemical markers, oxidative stress indicators, and histopathological features. The protective mechanisms appear multifactorial, involving direct antioxidant activity, enhancement of endogenous defense systems, and modulation of inflammatory pathways. In vivo hepatoprotective studies using the carbon tetrachloride (CCl₄)-induced hepatotoxicity model demonstrated dose-dependent protective effects of Daucus carota extract. Carbon tetrachloride, a well-established hepatotoxin, undergoes metabolic activation by cytochrome P₄₅₀ enzymes to form highly reactive trichloromethyl radicals that initiate lipid peroxidation, cellular membrane damage, and hepatocellular necrosis. Animals receiving CCl₄ alone exhibited dramatic elevations in serum liver enzymes: alanine aminotransferase (ALT) increased from normal baseline of 38.4 ± 3.2 U/L to 287.6 ± 18.4 U/L, aspartate aminotransferase (AST) rose from 42.3 ± 4.1 U/L to 312.8 ± 21.7 U/L, and alkaline phosphatase (ALP) increased from 95.7 ± 7.3 U/L to 268.4 ± 15.9 U/L. These elevated enzyme levels indicate severe hepatocellular damage with leakage of cytosolic and mitochondrial enzymes into circulation.

Fig.No.2 In vivo hepatoprotective studies of  extract of Daucus carota

Pretreatment with Daucus carota ethanolic extract at 200 mg/kg body weight for 7 days prior to CCl4 administration resulted in significant protection, reducing ALT to 148.3 ± 11.2 U/L (48% reduction compared to toxin control), AST to 165.4 ± 13.8 U/L (47% reduction), and ALP to 156.7 ± 10.4 U/L (42% reduction). The higher dose of 400 mg/kg demonstrated even greater hepatoprotection, with ALT at 95.2 ± 8.7 U/L (67% reduction), AST at 116.3 ± 9.4 U/L (63% reduction), and ALP at 112.5 ± 8.9 U/L (58% reduction). These values approached those achieved by the standard hepatoprotective drug silymarin at 100 mg/kg (ALT: 102.4 ± 9.1 U/L, AST: 115.7 ± 10.3 U/L, ALP: 128.3 ± 9.8 U/L), suggesting comparable efficacy. Statistical analysis confirmed highly significant differences (p<0.001) between toxin control and extract-treated groups, validating the hepatoprotective effect.

Oxidative stress parameters in liver tissue provided mechanistic insights into hepatoprotective action. Malondialdehyde (MDA), a lipid peroxidation product serving as a marker of oxidative damage, increased dramatically in CCl4-treated animals (8.7 ± 0.6 nmol/mg protein) compared to normal controls (1.8 ± 0.2 nmol/mg protein). Pretreatment with Daucus carota extract at 400 mg/kg significantly reduced MDA levels to 2.5 ± 0.3 nmol/mg protein, representing 71% inhibition of lipid peroxidation. This protection against oxidative damage to cellular membranes contributes critically to hepatocellular preservation.

Tissue antioxidant enzyme activities demonstrated enhancement of endogenous defense mechanisms. In CCl₄-treated animals, hepatic SOD activity decreased to 3.2 ± 0.3 U/mg protein from normal levels of 8.4 ± 0.7 U/mg protein, reflecting oxidative stress-induced depletion. Extract treatment at 400 mg/kg restored SOD activity to 7.8 ± 0.6 U/mg protein. Similarly, catalase activity recovered from 2.1 ± 0.2 to 5.3 ± 0.4 U/mg protein (normal: 6.1 ± 0.5 U/mg protein), and GPx activity increased from 4.3 ± 0.4 to 9.2 ± 0.7 U/mg protein (normal: 10.4 ± 0.9 U/mg protein). These restorations of enzymatic antioxidant defenses indicate that Daucus carota not only provides direct antioxidant activity through its phytochemical constituents but also upregulates endogenous protective systems, offering comprehensive oxidative stress mitigation. Complementary studies using paracetamol-induced hepatotoxicity model yielded similar protective outcomes, confirming the broad-spectrum hepatoprotective potential of Daucus carota against different toxic insults. The convergent results across multiple experimental models and assessment parameters establish robust evidence for hepatoprotective efficacy mediated through antioxidant mechanisms, supporting the traditional medicinal use of carrot and its potential development as a natural therapeutic agent for liver disorders.

DISCUSSION

The present investigation provides comprehensive pharmacological evidence establishing Daucus carota as a potent antioxidant and hepatoprotective agent, with efficacy mediated through multiple interconnected mechanisms. The robust correlation between high phytochemical content4particularly phenolic acids, flavonoids, and carotenoids4and the observed hepatoprotective effects supports the hypothesis that antioxidant activity constitutes the primary mechanism underlying liver protection. This research contributes significant scientific validation to traditional medicinal uses of carrot while elucidating specific molecular and cellular mechanisms that were previously incompletely understood.

The mechanistic insights gleaned from this research reveal that Daucus carota's hepatoprotective efficacy operates through a sophisticated multi-level defense strategy. At the primary level, the abundant phenolic compounds4particularly trans-ferulic acid and chlorogenic acid4function as potent free radical scavengers. These molecules possess multiple hydroxyl groups capable of donating hydrogen atoms to neutralize reactive oxygen species before they can initiate lipid peroxidation cascades in cellular membranes. The structure-activity relationships of these compounds have been well- characterized: the ortho-dihydroxy configuration on the aromatic ring provides optimal electron delocalization, stabilizing the resulting phenoxyl radical and effectively terminating oxidative chain reactions. Beyond direct radical scavenging, Daucus carota phytochemicals modulate cellular antioxidant enzyme expression through transcriptional mechanisms. The observed increases in SOD, catalase, and GPx activities following extract treatment suggest activation of the Nrf2-ARE (nuclear factor erythroid 2- related factor 2 - antioxidant response element) signaling pathway. Under oxidative stress conditions, Nrf2 translocates to the nucleus and binds to ARE sequences in the promoter regions of antioxidant enzyme genes, inducing their transcription. Phenolic compounds and flavonoids in Daucus carota can trigger this protective response either through mild pro-oxidant effects that activate Nrf2 as an adaptive response, or through direct modification of Keap1 (Kelch-like ECH-associated protein 1), the cytoplasmic repressor of Nrf2, allowing nuclear translocation. This indirect antioxidant mechanism provides sustained protection beyond the immediate presence of the phytochemicals, as the upregulated endogenous enzymes continue functioning even after the plant-derived compounds are metabolized.

5.1 Anti-inflammatory Mechanisms

The hepatoprotective effects observed extend beyond pure antioxidant mechanisms to include significant anti-inflammatory actions. Flavonoids, particularly quercetin and kaempferol derivatives present in Daucus carota, are established modulators of inflammatory signaling pathways. These compounds inhibit the nuclear factor-kappa B (NF-»B) pathway4a master regulator of inflammatory gene expression4by preventing degradation of I»B inhibitory proteins and subsequent nuclear translocation of NF-»B subunits. By suppressing NF-»B activation, Daucus carota extracts reduce transcription of pro-inflammatory cytokines including tumor necrosis factor-alpha (TNF-c), interleukin-6 (IL-6), and interleukin-1β (IL-1β). These cytokines, when overproduced during hepatotoxicity, amplify liver damage through recruitment of inflammatory cells, induction of hepatocyte apoptosis, and promotion of fibrogenic responses. The observed histopathological improvements4particularly the reduced inflammatory cell infiltration4provide visual confirmation of these anti-inflammatory effects.

Comparative analysis with standard hepatoprotective drugs reveals that Daucus carota extract at 400 mg/kg achieves efficacy comparable to silymarin at 100 mg/kg, the gold-standard natural hepatoprotective agent derived from milk thistle (Silybum marianum). Silymarin's mechanism involves antioxidant activity, membrane stabilization, stimulation of protein synthesis, and antifibrotic effects. The fact that Daucus carota demonstrates similar protective capacity suggests overlapping mechanisms while potentially offering advantages in terms of dietary accessibility, lower cost, and broader availability. Unlike silymarin, which requires specialized extraction from milk thistle seeds, Daucus carota represents a common food crop with worldwide cultivation, making it more feasible for large-scale application in preventive health strategies.

Comparison with other natural antioxidants provides additional context for the observed potency. The IC50 value of 18.7 ¿g/mL for DPPH radical scavenging positions Daucus carota ethanolic extract among moderately potent to potent natural antioxidants4comparable to green tea polyphenols (IC50 15-25 ¿g/mL) and superior to many common fruits and vegetables. The anthocyanin-rich purple carrot variety demonstrated even greater potency (IC50 11.4 ¿g/mL), approaching that of concentrated berry extracts known for exceptional antioxidant capacity. This variation among cultivars suggests opportunities for cultivar selection or breeding programs aimed at maximizing therapeutic phytochemical content. The potential applications of Daucus carota as a natural hepatoprotective and antioxidant agent span multiple domains. In the functional food sector, carrot-based formulations could be developed specifically targeting liver health, capitalizing on consumer preference for food-derived therapeutics over pharmaceutical interventions. Concentrated carrot extracts standardized to specific phytochemical content could serve as dietary supplements for individuals at risk of liver disease due to alcohol consumption, medication use, occupational chemical exposure, or metabolic disorders. The demonstrated safety profile of carrot consumption4supported by centuries of dietary use4represents a significant advantage over synthetic drugs that often carry concerns about adverse effects and drug-drug interactions.

In clinical contexts, Daucus carota extracts may serve as complementary therapeutic agents alongside conventional treatments for chronic liver diseases including non-alcoholic fatty liver disease (NAFLD), alcoholic liver disease, and drug-induced hepatotoxicity. The antioxidant and anti- inflammatory mechanisms could slow disease progression, reduce oxidative damage, and improve hepatic function markers. Importantly, the food- derived nature of these compounds typically results in excellent tolerability and minimal side effect profiles compared to synthetic hepatoprotective drugs.

From a public health perspective, promoting increased consumption of carrots and particularly phytochemical-rich varieties (purple and black carrots) could contribute to population-level reductions in oxidative stress-related diseases. The liver-protective effects demonstrated in this research add to the already established benefits of carrot consumption for vision (due to provitamin A carotenoids), cardiovascular health, and cancer prevention, strengthening the case for carrots as a key component of health-promoting dietary patterns.

Limitations and Future Directions

 While this research provides compelling evidence for hepatoprotective and antioxidant activities, several limitations warrant acknowledgment. The animal model studies, though scientifically rigorous, employed acute chemical hepatotoxicity induction that may not fully recapitulate the chronic, multifactorial pathogenesis of human liver diseases. Future investigations should explore efficacy in chronic liver disease models including dietary-induced NAFLD and alcoholic liver disease to better approximate clinical conditions. The in vivo studies utilized relatively short treatment durations; longer-term studies would help establish sustained efficacy and identify any potential long-term effects. Additionally, while the phytochemical composition was comprehensively characterized, the individual contribution of specific compounds versus synergistic interactions remains incompletely defined. Future research employing isolated compounds alongside whole extracts would clarify these structure-activity relationships.

The absence of human clinical trials represents the most significant limitation restricting immediate clinical application. While animal studies provide valuable mechanistic insights and preliminary efficacy data, human studies are essential for confirming therapeutic benefits, establishing appropriate dosing regimens, assessing bioavailability, and identifying potential individual variations in response. Well-designed randomized controlled trials in patients with liver disease are critically needed. Pharmacokinetic studies characterizing absorption, distribution, metabolism, and excretion of key Daucus carota phytochemicals would inform optimal formulation and dosing strategies. Investigation of potential interactions with common medications, particularly those metabolized by hepatic cytochrome P₄₅₀ enzymes, would be important for safe clinical integration. Despite these limitations, the present research establishes a solid scientific foundation supporting Daucus carota as a promising candidate for development as a natural hepatoprotective and antioxidant therapeutic agent, warranting continued investigation toward clinical application.

CONCLUSION

This comprehensive pharmacological investigation provides robust scientific evidence establishing Daucus carota (carrot) as a potent natural antioxidant and hepatoprotective agent. The research systematically characterized the phytochemical composition, quantified antioxidant capacity through multiple complementary assays, and demonstrated significant protective effects against chemically-induced liver damage in both in vitro and in vivo experimental models. The convergence of phytochemical, biochemical, and histopathological evidence establishes a clear mechanistic understanding of how carrot-derived bioactive compounds exert therapeutic effects through antioxidant and anti-inflammatory pathways.

The phytochemical analysis revealed that Daucus carota contains a sophisticated array of bioactive compounds working synergistically to produce therapeutic effects. The identification and quantification of specific compounds4particularly trans-ferulic acid (12.8 mg/100g) and chlorogenic acid (8.4 mg/100g) as predominant phenolic antioxidants, along with quercetin and kaempferol derivatives as major flavonoids4provides molecular-level understanding of the chemical basis for biological activities. The presence of carotenoids (c-carotene and β-carotene) and polyacetylenes adds additional mechanistic dimensions, creating a multi-component therapeutic system that likely exhibits advantages over single-compound drugs through synergistic interactions and multiple target engagement.

The antioxidant activity demonstrated across multiple assay systems4DPPH radical scavenging, ABTS radical cation decolorization, and FRAP reducing power assessment4confirms broad-spectrum free radical neutralization capacity operating through various mechanisms including hydrogen atom transfer, single electron transfer, and metal chelation. Beyond direct radical scavenging, the observed enhancement of enzymatic antioxidant defenses (SOD, catalase, and GPx activities) indicates that Daucus carota phytochemicals can upregulate endogenous protective systems, providing sustained antioxidant defense that extends beyond the immediate presence of the plant-derived compounds. This dual action4combining direct and indirect antioxidant mechanisms4represents a particularly effective approach to combating oxidative stress.

REFERENCES

1.      Ismail, S.M., Mohamed, A.A., s Hassan, R.A. (2023). Pharmacological properties and therapeutic potential of Daucus carota (wild carrot): A comprehensive review. Nutrients, 15(8), 1882.

2.      Deshmukh, P.B., Kale, R.N., s Deshpande, N.R. (2021). Pharmacological review on Daucus carota (carrot): A valuable medicinal plant. International Journal of Pharmacy and Pharmaceutical Research, 22(3), 456-478.

3.      Hadji, M., Boulaaba, M., s Brahmi, F. (2024). Phenolic profiling and antioxidant evaluation of Daucus carota subspecies: Comparative analysis of wild and cultivated varieties. Journal of Food Biochemistry, 48(2), e14521. https://doi.org/10.1111/jfbc.14521

4.      Singh, A., Kumar, S., s Sharma, R. (2025). Comparative antioxidant activity studies of colored carrot varieties: Purple, black, and orange cultivars. Food Chemistry, 412, 135847.

5.      Montilla, E.C., Arzaba, M.R., Hillebrand, S., s Winterhalter, P. (2011). Anthocyanin composition of black carrot (Daucus carota ssp. sativus var. atrorubens Alef.) cultivars Antonina, Beta Sweet, Deep Purple, and Purple Haze. Journal of Agricultural and Food Chemistry, 59(7), 3385-3390.

6.      6.Alasalvar, C., Grigor, J.M., Zhang, D., Quantick, P.C., s Shahidi, F. (2001). Comparison of volatiles, phenolics, sugars, antioxidant vitamins, and sensory quality of different colored carrot varieties. Journal of Agricultural and Food Chemistry, 49(3), 1410-1416.